Cresco Labs Inc. Deferred Income Tax Expense (Benefit)
Cresco Labs Inc. (CRLBF) reported Deferred Income Tax Expense (Benefit) of -$4.15 million for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-03-06
| Period end | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$4.15M 40-F · filed 2026-03-06 | |
| 2024-12-31 | -$2.79M 40-F · filed 2026-03-06 | $9.00K 40-F · filed 2025-03-14 |
| 2023-12-31 | -$35.43M 40-F · filed 2025-03-14 |